Even with national strategies in place to end the HIV epidemic, almost 1.2 million people remain at risk of sexually acquired HIV.¹ But there are ways you and your team can help patients lower their risk. Giving patients the knowledge they need, building trust through thorough conversations, and encouraging adherence to PrEP medication are just a few topics that will be discussed in this live broadcast.
Join us on September 23, 2020 at 3:00 PM EDT to hear about care team strategies when it comes to HIV prevention and the selection of a PrEP option.
1. Smith DK, et al. Ann Epidemiol. 2018;28(12):850-857.e9.
Please click HERE to see full Prescribing Information for DESCOVY® (emtricitabine 200mg/tenofovir alafenamide 25 mg tablets) FOR PrEP, including BOXED WARNING.